Lv1
90 积分 2024-10-29 加入
Anticoagulation in cirrhosis
6天前
已完结
Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study
8天前
已完结
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
8天前
已完结
Atrial fibrillation
19天前
已完结
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
25天前
已完结
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
1个月前
已完结
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
1个月前
已完结
Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study
1个月前
已完结
Safety and Efficacy of Direct Oral Anticoagulants in Patients With Moderate to Severe Cirrhosis
1个月前
已完结
The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023
1个月前
已完结
皖公网安备34019202002308
